Wishing you all the joys of the season! 
Balloon Aortic Valvuloplasty Market Size and Forecast (2021-2031)
Balloon Aortic Valvuloplasty Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Non-Compliant Balloons and Semi-Compliant Balloons) and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
$3,633 – $6,433
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
TAVR was originally considered only for patients with severe aortic stenosis who were considered inoperable or at very high risk. However, continuous technological evolution in valve technology and the results of randomized trials have expanded its usage to younger and lower-risk patients, making it a mainstream treatment for aortic valve disease. With developments in valve production technologies, bioprosthetic heart valves are becoming more popular and applicable to younger and lower-risk patients. With its minimally invasive feature, a majority of valve replacements will soon be via TAVR. New-generation transcatheter heart valves have substantially improved procedural efficacy, safety, and patient outcomes, making TAVR an appealing option for different patient risk groups.
Predicting the performance of the heart valve upon implantation is critically important for a successful TAVR. It is desirable to mechanically assess selected heart valves before implantation to ensure proper valve function with minimal complications after implantation. A potential practical and effective solution for applying engineering analysis to the mechanical assessment of heart valves is incorporating deep learning (DL)-based systems to advance and simplify the computational biomechanical analyses relevant to TAVR. In recent years, immense developments in DL techniques have led to state-of-the-art performances in many computer vision tasks, including image classification, image segmentation, and object detection. DL has been extensively investigated for various cardiac imaging applications, including diagnostic, prognostic, risk stratification, and therapeutic/surgical treatment planning. Numerous studies have investigated DL approaches for assessing TAVR outcomes to predict postoperative complications and prosthetic valve defects.
Through continuous research and development, the future of TAVR promises breakthrough possibilities, further strengthening its place as a transformative therapy in cardiovascular medicine. Currently, only the Edwards SAPIEN 3 Ultra, Medtronic EVOLUT FX, and Abbott Navitor valves have been approved by the FDA. Although most of the clinical experience with TAVR is linked to the Edwards and Medtronic valve systems, the potential transcatheter heart valves lineup extends beyond these leaders, with as many as five to ten new TAVR valves in the development phase. The future of TAVR appears bright, with indications growing, procedural volumes soaring, and an increasing number of clinical sites offering the procedure, although long-term durability remains a key concern. The leaflets of currently available valves are derived from porcine or bovine pericardial tissue. New valve platforms incorporating creative leaflet materials and other design innovations are being developed to increase long-term durability. Some new trials promise to offer crucial guidance for TAVR operators seeking to offer long-term solutions. The SMART (i.e., SMall Annuli Randomized to Evolut or SAPIEN) trial is the first randomized industry-sponsored (Medtronic) head-to-head comparison of the two most commonly used TAVR devices: SAPIEN 3 and Evolut in small anatomies. The trial was conducted at 83 international sites in North America, Europe, and the Middle East & Africa. The trial enrolled 716 participants with a small aortic annulus (aortic annulus area of 430 mm2 or less based on multi-detector computed tomography) and symptomatic severe native aortic stenosis. In April 2024, the American College of Cardiology announced that findings from the SMART trial demonstrated that patients with a small aortic annulus who underwent TAVR with Evolut valve had similar clinical outcomes and superior valve performance at one year compared with patients who underwent TAVR with SAPIEN 3 valve. Researchers said the results are encouraging in terms of the clinical outcomes of both valve types. Researchers will continue to track outcomes over the next five years. Thus, research and development activities focused on improving TAVI procedures are likely to bring in new trends in the balloon aortic valvuloplasty market.
Product Type -Based Insights
Based on product type, the balloon aortic valvuloplasty market is segmented into non compliant balloons and semi compliant balloons. The non compliant balloons segment held a larger balloon aortic valvuloplasty market share in 2023 and is expected to register a higher CAGR in the market during 2023–2031.
National Echo Database of Australia and the Institute of Health Economics are among the primary and secondary sources referred to while preparing the balloon aortic valvuloplasty market report.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
The scope of the balloon aortic valvuloplasty market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. Asia Pacific is anticipated to register the fastest CAGR in the balloon aortic valvuloplasty market from 2023 to 2031. From a few centers over a decade ago, TAVI is now performed in about 260 centers throughout Northeast Asia, Southeast Asia, and the Indian subcontinent. As the population in Asia advances in age, the demand for TAVI is poised to increase simultaneously. As per a study, “Economic Evaluation of Transcatheter Aortic Valve Replacement Compared to Surgical Aortic Valve Replacement in Chinese Intermediate-Risk Patients,” published in May 2022, the prevalence of aortic stenosis was 0.16% in patients younger than 65 years and 0.41% and 0.56% in people aged 65–74 and above 75 years, respectively. According to the study “The current practice of transcatheter aortic valve replacement in China,” published in the National Center for Biotechnology Information in August 2022, TAVR device implementation procedures were successful in 97.85% of patients who underwent transcatheter aortic valve replacement procedures in the country in 2022.
According to the Circulation Report from the Official Journal of the Japanese Circulation Society published in 2020, TAVI has been available in Japan since October 2013. The latest guideline on managing valvular heart disease recommends surgical aortic valve replacement (SAVR) for patients aged <75 years and TAVI for patients aged ≥80 years, regardless of the risks associated with the surgery.
The National Echo Database of Australia data 2021 revealed that 97,379 Australians suffered from severe aortic stenosis. The number of moderate to severe aortic stenosis cases in Australia is estimated to grow to 200,000 patients in 2031 and 266,000 by 2051. The growing prevalence of aortic valve stenosis is surging the demand for balloon aortic valvuloplasty (BAV) devices, as BAV is a minimally invasive procedure utilized to treat aortic valve stenosis. In addition, as stated in the article "Aortic valve replacement rates in Australia from 2004 to 2019," published in PubMed in 2022, about 2,683 TAVI procedures were performed in 2019 in Australia, representing a 52% annual increase from 2014. BAV increased from 66 procedures in 2004 to 862 in 2019. Rates of aortic valve replacements have increased significantly over the past 16 years, especially in older people.
Further, the thriving medical tourism industry in India, China, and Malaysia attracts heart patients worldwide for treatment, facilitating the balloon aortic valvuloplasty market growth. Although the cost of medical treatments can be a significant issue for many individuals, it is reassuring that India offers cost-effective TAVI procedures compared to many Western countries. The cost-effectiveness of TAVI in the country does not compromise the quality of care, as the country boasts some of the world’s most skilled and experienced cardiac specialists and state-of-the-art medical facilities. As the medical field progresses, India's commitment to providing affordable healthcare options ensures that patients globally can access cutting-edge treatments, including TAVI.
As market players offer more device alternatives due to advancements in technology, access to TAVR procedures will increase significantly, supporting the balloon aortic valvuloplasty market growth. Edwards Lifesciences Corp. received Chinese regulatory approval for the Edwards Sapien 3 TAVR system in June 2020 to treat patients suffering from severe, symptomatic aortic stenosis or are at high risk for developing aortic stenosis or unable to undergo open-heart surgery. The approval marked a significant milestone for the country’s physicians and their patients living with severe aortic stenosis in need of alternatives to open-heart surgery. Additionally, in April 2024, Siriraj Hospital, a leading healthcare institution in Thailand, stood at the forefront of aortic valve disease treatment with TAVI. The minimally invasive procedure reduces surgical trauma and post-surgery recovery time when compared to open-heart surgery, providing a viable option for high-risk patients. In 2010, Siriraj Hospital was the first hospital in Thailand to introduce the TAVI procedure for patients who were unable to receive a SAVR. The hospital now provides TAVI as a treatment option for patients with intermediate risks for SAVR and patients aged over 80 years. Thus, these factors mentioned above support the growth of balloon aortic valvuloplasty market.
Technological advancements by the companies in balloon aortic valvuloplasty favor the growth of balloon aortic valvuloplasty market. In 2021, Peijia Medical, a leading Chinese player in the transcatheter valve therapeutic and neuro-interventional procedural medical device market, launched its second-generation TaurusElite TAVR system after obtaining regulatory approval in China. Additionally, in January 2022, JenaValve Technology, Inc. announced a strategic investment and exclusive technology licensing agreement with Peijia Medical Limited in China. Under the terms of the agreement, Peijia obtained exclusive rights to develop and commercialize JenaValve’s Trilogy TAVR system in the Greater China region to treat patients with severe symptomatic aortic regurgitation or symptomatic aortic stenosis. In 2021, the company started clinical trials for its third-generation TAVR system. In July 2023, Peijia Medical enrolled the first Chinese patient in its multicenter clinical trial for these TAVR systems.
Apart from the Sapien 3, the Chinese regulatory has approved three locally manufactured valves: the Venus-A valve (Venus MedTech), J-Valve (Jie Cheng Medical Technologies), and MicroPort VitaFlow valve (MicroPort Medical). Two indigenous valves are available in India: MyVal (a balloon-expandable system from Meril Life Sciences Pvt Ltd) and Hydra (a self-expanding system from Vascular Innovations Co Ltd). Thus, the approval of these domestic valves promoted the rapid development of TAVI in both countries. TAVI has emerged as a ground‐breaking, minimally invasive choice to traditional open‐heart surgery, primarily designed for aged patients who were considered unsuitable for surgical intervention due to severe aortic stenosis. Thus, the abovementioned factors support the balloon aortic valvuloplasty market growth in the region.
B Braun SE, TT Medical, Inc., Balton, Becton Dickinson and Co, Edwards Lifesciences Corp, Balt, Venus MedTech HangZhou Inc., NuMED, simeks, and OSYPKA are among the leading companies profiled in the balloon aortic valvuloplasty market report.
Balloon Aortic Valvuloplasty Market, by Region, 2023 (%)
Source: the Research Team Analysis
Based on product type, the market is segmented into non compliant balloons and semi compliant balloons. Geographically, the balloon aortic valvuloplasty market is categorized into North America (Canada and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the balloon aortic valvuloplasty market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Balloon Aortic Valvuloplasty Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Regional Pricing Analysis, By Product Type, 2023
5. Balloon Aortic Valvuloplasty Market – Key Market Dynamics
5.1 Balloon Aortic Valvuloplasty Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Aortic Valve Stenosis
5.2.2 Increasing Demand for Minimally Invasive Procedures
5.3 Market Restraints
5.3.1 High Cost of Procedures
5.4 Market Opportunities
5.4.1 Advancements in Aortic Valve Replacement Technologies
5.5 Future Trends
5.5.1 Improvements in TAVI Combined with Research and Development
5.6 Impact of Drivers and Restraints:
6. Balloon Aortic Valvuloplasty Market – Global Market Analysis
6.1 Balloon Aortic Valvuloplasty Market Revenue (US$ Thousand), 2021–2031
6.2 Market Positioning Analysis, 2023
7. Balloon Aortic Valvuloplasty Market Analysis – by Product Type
7.1 Overview
7.2 Global: Balloon Aortic Valvuloplasty Market – – Revenue and Forecast Analysis – by Product Type
7.3 Global: Balloon Aortic Valvuloplasty Market – – Volume and Forecast Analysis – by Product Type
7.4 Non Compliant Balloons
7.4.1 Overview
7.4.2 Non Compliant Balloons: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
7.5 Semi Compliant Balloons
7.5.1 Overview
7.5.2 Semi Compliant Balloons: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8. Balloon Aortic Valvuloplasty Market – Geographical Analysis
8.1 Overview
8.2 North America
8.2.1 North America Balloon Aortic Valvuloplasty Market Overview
8.2.2 North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2.3 North America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.2.3.1 North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.2.3.2 North America: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis – by Product Type
8.2.4 North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.2.4.1 Canada: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2.4.1.1 Canada: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.2.4.1.2 Canada: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.2.4.2 Mexico: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2.4.2.1 Mexico: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.2.4.2.2 Mexico: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3 Europe
8.3.1 Europe Balloon Aortic Valvuloplasty Market Overview
8.3.2 Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.3 Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.3.1 Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.3.3.2 Europe: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4 Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.3.4.1 Germany: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.1.1 Germany: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.1.2 Germany: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.2 United Kingdom: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.2.1 United Kingdom: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.2.2 United Kingdom: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.3 France: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.3.1 France: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.3.2 France: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.4 Italy: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.4.1 Italy: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.4.2 Italy: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.5 Spain: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.5.1 Spain: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.5.2 Spain: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.3.4.6 Rest of Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3.4.6.1 Rest of Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.3.4.6.2 Rest of Europe: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4 Asia Pacific
8.4.1 Asia Pacific Balloon Aortic Valvuloplasty Market Overview
8.4.2 Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.3 Asia Pacific: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.3.1 Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.4.3.2 Asia Pacific: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4 Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.4.4.1 China: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.1.1 China: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.1.2 China: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.2 Japan: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.2.1 Japan: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.2.2 Japan: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.3 India: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.3.1 India: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.3.2 India: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.4 South Korea: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.4.1 South Korea: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.4.2 South Korea: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.5 Australia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.5.1 Australia: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.5.2 Australia: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.4.4.6 Rest of APAC: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.4.4.6.1 Rest of APAC: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.4.4.6.2 Rest of APAC: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5 Middle East and Africa
8.5.1 Middle East and Africa Balloon Aortic Valvuloplasty Market Overview
8.5.2 Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.3 Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.3.1 Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.5.3.2 Middle East and Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5.4 Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.5.4.1 Saudi Arabia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.4.1.1 Saudi Arabia: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.4.1.2 Saudi Arabia: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5.4.2 South Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.4.2.1 South Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.4.2.2 South Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5.4.3 United Arab Emirates: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.4.3.1 United Arab Emirates: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.4.3.2 United Arab Emirates: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.5.4.4 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.5.4.4.1 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.5.4.4.2 Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.6 South and Central America
8.6.1 South and Central America Balloon Aortic Valvuloplasty Market Overview
8.6.2 South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6.3 South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.6.3.1 South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Product Type
8.6.3.2 South and Central America: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.6.4 South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast Analysis – by Country
8.6.4.1 Brazil: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6.4.1.1 Brazil: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.6.4.1.2 Brazil: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.6.4.2 Argentina: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6.4.2.1 Argentina: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.6.4.2.2 Argentina: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
8.6.4.3 Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
8.6.4.3.1 Rest of South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
8.6.4.3.2 Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Volume and Forecast Analysis (Units) – by Product Type
9. Company Profiles
9.1 B Braun SE
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Products and Services
9.1.4 Financial Overview
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 TT Medical, Inc.
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Products and Services
9.2.4 Financial Overview
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 Balton
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Products and Services
9.3.4 Financial Overview
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 Becton Dickinson and Co
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Products and Services
9.4.4 Financial Overview
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 Edwards Lifesciences Corp
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Products and Services
9.5.4 Financial Overview
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 Balt
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Products and Services
9.6.4 Financial Overview
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Venus MedTech HangZhou Inc
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Products and Services
9.7.4 Financial Overview
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 NuMED
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Products and Services
9.8.4 Financial Overview
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Simeks
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Products and Services
9.9.4 Financial Overview
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 OSYPKA
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Products and Services
9.10.4 Financial Overview
9.10.5 SWOT Analysis
9.10.6 Key Developments
10. Appendix
10.1 About the Research Team
LIST OF TABLES
Table 1. Balloon Aortic Valvuloplasty Market Segmentation
Table 2. Regional Pricing Analysis, By Product Type, 2023
Table 3. Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand) – by Product Type
Table 4. Global: Balloon Aortic Valvuloplasty Market – Volume (Units) and Forecast to 2031(Units) – by Product Type
Table 5. North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 6. North America: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031(Units) – by Product Type
Table 7. Canada: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 8. Canada: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 9. Mexico: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 10. Mexico: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 11. Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 12. Europe: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 13. Germany: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 14. Germany: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 15. United Kingdom: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 16. United Kingdom: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 17. France: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 18. France: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 19. Italy: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 20. Italy: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 21. Spain: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 22. Spain: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 23. Rest of Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 24. Rest of Europe: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 25. Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 26. Asia Pacific: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 27. China: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 28. China: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 29. Japan: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 30. Japan: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 31. India: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 32. India: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 33. South Korea: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 34. South Korea: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 35. Australia:
Table 36. Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 37. Australia: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 38. Rest of APAC: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 39. Rest of APAC: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 40. Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 41. Middle East and Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 42. Saudi Arabia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 43. Saudi Arabia: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 44. South Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 45. South Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 46. United Arab Emirates: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 47. United Arab Emirates: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 48. Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 49. Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 50. South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 51. South and Central America: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 52. Brazil: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 53. Brazil: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 54. Argentina: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 55. Argentina: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 56. Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand) – by Product Type
Table 57. Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 58. Appendix: Balloon Aortic Valvuloplasty Market
LIST OF FIGURES
Figure 1. Balloon Aortic Valvuloplasty Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Balloon Aortic Valvuloplasty Market Revenue (US$ Thousand), 2021–2031
Figure 5. Ballon Aortic Valvuloplasty Market, By Geography Forecast Analysis, 2023 & 2031
Figure 6. Market Positioning Analysis, 2023
Figure 7. Balloon Aortic Valvuloplasty Market Share (%) – by Product Type (2023 and 2031)
Figure 8. Non Compliant Balloons: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 9. Semi Compliant Balloons: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 10. Balloon Aortic Valvuloplasty Market Breakdown by Region, 2023 and 2031 (%)
Figure 11. North America: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 12. North America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. North America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 14. North America: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 15. Canada: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 16. Mexico: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 17. Europe: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 18. Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 19. Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 20. Europe: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. Germany: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 22. United Kingdom: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 23. France: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 24. Italy: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 25. Spain: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 26. Rest of Europe: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 27. Asia Pacific: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 28. Asia Pacific: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 29. Asia Pacific: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 30. Asia Pacific: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. China: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 32. Japan: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 33. India: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 34. South Korea: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 35. Australia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 36. Rest of APAC: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 37. Middle East and Africa: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 38. Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 39. Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 40. Middle East and Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 41. Saudi Arabia: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 42. South Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 43. United Arab Emirates: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 44. Rest of Middle East and Africa: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 45. South and Central America: Ballon Aortic Valvuloplasty Market by Key Countries – Revenue 2023 (US$ Thousand)
Figure 46. South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 47. South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Product Type (2023 and 2031)
Figure 48. South and Central America: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 49. Brazil: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 50. Argentina: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 51. Rest of South and Central America: Balloon Aortic Valvuloplasty Market – Revenue and Forecast to 2031(US$ Thousand)
The List of Companies – Balloon Aortic Valvuloplasty Market
o B Braun SE
o TT Medical, Inc.
o Balton
o Becton Dickinson and Co
o Edwards Lifesciences Corp
o Balt
o Venus MedTech HangZhou Inc
o NuMED
o simeks
o OSYPKA
You must be logged in to post a review.
Reviews
There are no reviews yet.